02.08.2022 22:08:01

Rigel Pharmaceuticals Inc. Q2 Loss beats estimates

(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) announced Loss for second quarter that beat the Street estimates.

The company's bottom line totaled -$13.49 million, or -$0.08 per share. This compares with -$13.82 million, or -$0.08 per share, in last year's second quarter.

Analysts on average had expected the company to earn -$0.12 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 13.5% to $29.82 million from $26.27 million last year.

Rigel Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings (Q2): -$13.49 Mln. vs. -$13.82 Mln. last year. -EPS (Q2): -$0.08 vs. -$0.08 last year. -Analyst Estimates: -$0.12 -Revenue (Q2): $29.82 Mln vs. $26.27 Mln last year.

Nachrichten zu Rigel Pharmaceuticals IncShsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Rigel Pharmaceuticals IncShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!